✦ LIBER ✦

Tu1142 Secondary Infliximab Treatment Failure in Crohn's Disease: Therapeutic Implications of Measuring Drug and Anti-Drug Antibodies by Three Different Binding Assays

✍ Scribed by Steenholdt, Casper; Brynskov, Jorn; Thomsen, Ole.; Munck, Lars K.; Fallingborg, Jan; Christensen, Lisbet A.; Pedersen, Gitte; Kjeldsen, Jens; Bendtzen, Klaus; Ainsworth, Mark A.

Book ID: 122163117
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 258 KB
Volume: 144
Category: Article
ISSN: 0016-5085
DOI: 10.1016/S0016-5085(13)62858-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P374 Secondary infliximab treatment fail

P374 Secondary infliximab treatment failure in Crohn's disease: therapeutic implications of measuring drug and anti-drug antibodies by three different binding assays

✍ Steenholdt, C.; Brynskov, J.; Thomsen, O.; Munck, L.; Fallingborg, J.; Christens 📂 Article 📅 2013 🏛 Oxford University Press 🌐 English ⚖ 89 KB

Sa1243 Clinical Implications of Measurin

Sa1243 Clinical Implications of Measuring Drug and Anti-Drug Antibodies by Different Assays When Optimizing Infliximab Treatment Failure in Crohn's Disease

✍ Steenholdt, Casper; Bendtzen, Klaus; Brynskov, Jorn; Thomsen, Ole.; Ainsworth, M 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 107 KB

P536 Clinical implications of measuring

P536 Clinical implications of measuring drug and anti-drug antibodies by different assays when optimizing infliximab treatment failure in Crohn's disease

✍ Steenholdt, C.; Bendtzen, K.; Brynskov, J.; Thomsen, O.Ø.; Ainsworth, M.A. 📂 Article 📅 2014 🏛 Oxford University Press 🌐 English ⚖ 48 KB

Clinical Implications of Measuring Drug

Clinical Implications of Measuring Drug and Anti-Drug Antibodies by Different Assays When Optimizing Infliximab Treatment Failure in Crohn's Disease: Post Hoc Analysis of a Randomized Controlled Trial

✍ Steenholdt, Casper; Bendtzen, Klaus; Brynskov, Jørn; Thomsen, Ole \[emptyv]; Ain 📂 Article 📅 2014 🏛 Nature Publishing Group 🌐 English ⚖ 273 KB